Ozanimod
Drug Details
- Generic Name
- Ozanimod
- Brand Names
- N/A
- Application Number
- Sponsor
- Chunghwa Chemical Synthesis & Biotech Co., Ltd.
- NDC Codes
- 1
- Dosage Forms
- POWDER
- Routes
- N/A
- Active Ingredients
- OZANIMOD
Indications and Usage
1 INDICATIONS AND USAGE ZEPOSIA is indicated for the treatment of: • relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. • moderately to severely active ulcerative colitis (UC) in adults. ZEPOSIA is a sphingosine 1-phosphate receptor modulator indicated for the treatment of: • Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 ) • Moderately to severely active ulcerative colitis (UC) in adults. ( 1 )